Q1 2026 Holdings
Filed 2026-05-14 | 76 holdings | $372.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aktis Oncology Inc(AKTS) | COM | 01021M104 | $56.6M | 3,161,348 | 15.2% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $32.0M | 7,120,007 | 8.6% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $30.1M | 4,416,353 | 8.1% |
| Nuveen Churchill Direct Lend(NCDL) | COM SHS | 67090S108 | $27.3M | 2,143,626 | 7.3% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $27.1M | 1,909,764 | 7.3% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $22.6M | 2,045,070 | 6.1% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $20.5M | 1,005,929 | 5.5% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $15.6M | 2,941,525 | 4.2% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $13.3M | 5,089,015 | 3.6% |
| Holley Inc(HLLY) | COM | 43538H103 | $13.0M | 4,236,888 | 3.5% |
| Eyepoint Inc(EYPT) | COM NEW | 30233G209 | $11.8M | 912,594 | 3.2% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $8.0M | 545,000 | 2.1% |
| Conduent Inc(CNDT) | COM | 206787103 | $6.4M | 5,036,595 | 1.7% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $6.3M | 302,638 | 1.7% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $5.6M | 1,347,932 | 1.5% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $5.3M | 61,455 | 1.4% |
| Compass Pathways PLC | CALL | 20451W901 | $5.1M | 1,804,504 | 1.4% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $5.0M | 547,552 | 1.3% |
| Imagenebio Inc(IMA) | COM | 45175G207 | $4.8M | 959,337 | 1.3% |
| Civeo Corp CDA(CVEO) | COM NEW | 17878Y207 | $4.8M | 180,475 | 1.3% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $4.6M | 506,722 | 1.2% |
| Eledon Pharmaceuticals Inc(ELDN) | COM | 28617K101 | $4.4M | 1,419,912 | 1.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $4.3M | 215,000 | 1.2% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $4.2M | 1,904,666 | 1.1% |
| Palvella Therapeutics Inc NE(PVLA) | COM | 697947109 | $3.9M | 31,259 | 1.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $3.7M | 2,969,199 | 1.0% |
| Starwood Ppty TR Inc(STWD) | COM | 85571B105 | $2.7M | 158,545 | 0.7% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $2.6M | 733,568 | 0.7% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $2.3M | 100,000 | 0.6% |
| Dell Technologies Inc(DELL) | CL C | 24703L202 | $2.3M | 13,899 | 0.6% |
| Larimar Therapeutics Inc | CALL | 517125900 | $1.9M | 975,700 | 0.5% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $1.9M | 150,000 | 0.5% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $1.7M | 333,877 | 0.5% |
| WW Intl Inc(WW) | COM NEW | 98262P200 | $1.3M | 95,634 | 0.4% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $1.3M | 511,177 | 0.3% |
| Enterprise Prods Partners L(EPD) | COM | 293792107 | $1.2M | 31,290 | 0.3% |
| Fold Hldgs Inc(FLD) | COM CL A | 29103K100 | $1.1M | 856,632 | 0.3% |
| Syntec Optics Hldgs Inc(OPTXW) | *W EXP 99/99/999 | 87169M113 | $867.4K | 803,132 | 0.2% |
| Marker Therapeutics Inc(MRKR) | COM NEW | 57055L206 | $720.5K | 554,250 | 0.2% |
| Mineralys Therapeutics Inc | CALL | 603170901 | $590.0K | 200,000 | 0.2% |
| Niocorp Devs LTD(NIOBW) | *W EXP 03/17/202 | 654484153 | $525.0K | 320,100 | 0.1% |
| Compass Therapeutics Inc | CALL | 20454B904 | $500.0K | 400,000 | 0.1% |
| Brand Engagement Network Inc(BNAIW) | *W EXP 03/14/202 | 104932116 | $416.7K | 1,666,808 | 0.1% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $363.0K | 1,718 | 0.1% |
| Rezolve AI PLC | *W EXP 08/15/202 | G75398118 | $202.2K | 235,121 | 0.1% |
| Piper Sandler Companies(PIPR) | COM NEW | 724078209 | $185.9K | 2,428 | 0.0% |
| Alpha Modus Hldgs Inc(AMOD) | CL A | 020952107 | $145.8K | 394,078 | 0.0% |
| Energy Transfer L P(ET) | COM UT LTD PTN | 29273V100 | $102.8K | 5,326 | 0.0% |
| CID Holdco Inc(DAIC) | COM | 171756109 | $94.8K | 557,361 | 0.0% |
| Caris Life Sciences Inc(CAI) | COM | 142152107 | $84.2K | 4,711 | 0.0% |